Clinical Trials Directory

Trials / Unknown

UnknownNCT01686191

Genetic Predictors of Renal Dysfunction Following Heart Transplantation

Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Kidney disease is a common problem after heart transplantation. It may be caused by anti-rejection medications such as cyclosporine or tacrolimus. However, the reason why some people develop kidney problems after a heart transplant, but other people do not, is not fully known. This study plans to learn more about the relationship between a person's genetic make-up (DNA; deoxyribonucleic acid) and the risk of kidney problems after a heart transplant. The long-term goal of this research is to identify genetic variations that may help predict the development of kidney problems after heart transplantation.

Conditions

Timeline

Start date
2012-08-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2012-09-17
Last updated
2023-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01686191. Inclusion in this directory is not an endorsement.